Insectta is Singapore's first ento-powered biotech company. Our patented extraction technology produces high-value biomaterials for the pharmaceutical, organic electronics, personal wellness industries, and more.

At the forefront of our solutions is sustainably-produced chitosan and melanin, with better functionality and yield than ever before. We're improving accessibility to these high-quality ingredients for manufacturers looking to optimise both performance and circularity. 

Founded in 2018, Insectta has grown from Singapore's very first insect company, to the world's first chemical manufacturer specialising in ento-biomaterials. We've raised $2.4M in funding, that has allowed us to bring our technology to scale and our biomaterials to the world. 

The future of circular biomaterials is looking fly - join us as we revolutionise the landscape of our healthcare and electronics

Insectta

Org chart

Teams

Offices